Loading…
読む『Pharma Medica』から、聴く『Pharma Medica』へ。1983年創刊の内科系総合学術誌『Pharma Medica』（発行：メディカルレビュー社）が、PODCASTとして新たにスタートします。医学と薬学の交差点から、common diseaseからrare diseaseまで、臨床医が押さえておきたい学術トピックスを、移動中やすき間時間に“耳で”アップデートできます。※本PODCASTの読み上げ音声はAIを使用して作成しています。
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
28%
Guest openness
Selective
Sign up to generate a grounded pitch for 耳で読む Pharma Medica.
Signup to Generate a Pitch耳で読む Pharma Medica is a health podcast hosted by メディカルレビュー社, with 12 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.
メディカルレビュー社 hosts 耳で読む Pharma Medica, a health show with 12 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
耳で読む Pharma Medica
Aritomi T, Sonomoto K, Nakayamada S, et al. Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Do Not Arrest Bone Loss in Patients With Rheumatoid Arthritis: A Long-Term Multicenter Observational Study. Arthritis Rheumatol. 2026 Mar 8（Epub ahead of print）. doi: 10.1002/art.70125.
耳で読む Pharma Medica
Yau WW, Kirn DR, Rabin JS, et al. Physical activity as a modifiable risk factor in preclinical Alzheimer's disease. Nat Med. 2025; 31: 4075-83. doi: 10.1038/s41591-025-03955-6.
耳で読む Pharma Medica
<p>Yau WW, Kirn DR, Rabin JS, et al. Physical activity as a modifiable risk factor in preclinical Alzheimer's disease. Nat Med. 2025; 31: 4075-83. <br>doi: 10.1038/s41591-025-03955-6. </p>
耳で読む Pharma Medica
Gold LS, Armstrong AW, Bissonnette R, et al. Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials. Lancet. 2025;406:1363-74. doi: 10.1016/S0140-6736(25)01576-4.
耳で読む Pharma Medica
<p>Gold LS, Armstrong AW, Bissonnette R, et al. Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials. Lancet. 2025;406:1363-74. </p><p>doi: 10.1016/S0140-6736(25)01576-4. </p>
Sponsor detection runs nightly. Check back soon.
Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
